HCP Connect Contributor
Dr. Sanjay Iyer
Dr. Sanjay Iyer contributes gastroenterology drug update coverage for HCP Connect, with emphasis on source-verified therapeutic developments and practical clinical context for US-licensed practitioners. This profile links the author's recent clinical coverage, specialty focus, and professional contributor metadata in one place.
Recent Drug Updates
10 total
Gastroenterology
FDA Approves Bulevirtide for HDV: 48% Combined Response in MYR301
Bulevirtide (Hepcludex) approved for chronic hepatitis delta virus: 48% combined response in MYR301 trial.
Gastroenterology
FDA Approves Wegovy for MASH: 63% Resolution Rate in Ongoing Trial
FDA approves Wegovy for MASH treatment, showing 63% resolution rate in ongoing trial.
Gastroenterology
FDA Approves Lynavoy for Cholestatic Pruritus: Treatment of Primary Biliary Cholangitis
FDA approves Lynavoy for cholestatic pruritus in primary biliary cholangitis, offering new treatment options for patients.
Gastroenterology
FDA Approves New Biologics Algorithm for Ulcerative Colitis: Golimumab, Vedolizumab, Upadacitinib, and More
FDA approves new biologics algorithm for ulcerative colitis: golimumab, vedolizumab, upadacitinib, and more.
Healthcare Business
AI Prior Auth: 30% Reimbursement Risk for 6 States
New Medicare pilot program introduces AI-powered prior authorization, potentially reducing reimbursement for certain medical procedures in 6 states, sparking concerns among healthc...
Medical Research
Uncover Lipid Metabolism Secrets to Diagnose MASLD
Discover how lipid droplets in hepatocytes contribute to hepatic steatosis in MASLD, a key to accurate diagnosis and treatment of the condition.
Digital Health
Clear Digital Leadership: Boost NHS Transformation
Discover how clear digital leadership can accelerate NHS transformation and reduce duplication, improving healthcare outcomes and efficiency.
Medical Research
COVID-19 Shot Guidance: What to Expect
Get the latest on potential changes to COVID-19, hepatitis B, and chickenpox vaccine recommendations and their impact on your practice.
Health Information
Cut Vaping Costs with Longer-Lasting Devices
Discover how high-puff vapes can reduce overhead costs and provide better value for patients who vape, with devices delivering up to 60,000 puffs.
Medical Research
Cut PMADs by 20% with Proper Screenings
Improve maternal mental health outcomes by identifying gaps in perinatal mood and anxiety disorder screenings and support systems for new mothers.